Literature DB >> 3950744

Effect of nimodipine on intracellular brain pH, cortical blood flow, and EEG in experimental focal cerebral ischemia.

F B Meyer, R E Anderson, T L Yaksh, T M Sundt.   

Abstract

Intracellular brain pH, cortical blood flow, and electroencephalograms (EEG's) were recorded in severely and moderately ischemic regions in 10 control and 10 nimodipine-treated rabbits prior to and following major branch occlusion of the middle cerebral artery (MCA). Preocclusion cortical blood flow was 51 ml/100 gm/min and intracellular brain pH was 7.01 in both the control and the treated animals. After MCA occlusion, the severely ischemic regions in the control group showed initial and 4-hour postocclusion flows of 12.7 and 5.2 ml/100 gm/min with a brain pH of 6.64 and 6.08, respectively. In animals given nimodipine after MCA occlusion, blood flow increased from 10.5 to 18.8 ml/100 gm/min, with an associated elevation in intracellular brain pH from 6.57 to 6.91. Comparable findings were observed in areas of moderate ischemia. Improvements in cortical blood flow, intracellular brain pH, and EEG attenuations produced by nimodipine were all statistically significant. Inspection of the cortex revealed reversal of cortical pallor and small-vessel spasm following treatment with nimodipine. It is hypothesized that nimodipine exerts its effects through reversal of ischemia-induced secondary vasoconstriction, and that this drug may be an important adjunctive treatment for patients with focal cerebral ischemia.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3950744     DOI: 10.3171/jns.1986.64.4.0617

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  11 in total

1.  A quantitative EEG method for detecting post clamp changes during carotid endarterectomy.

Authors:  Meenakshi Mishra; Muhammed Banday; Reza Derakhshani; John Croom; Paul J Camarata
Journal:  J Clin Monit Comput       Date:  2011-09-30       Impact factor: 2.502

Review 2.  Brain protection: physiological and pharmacological considerations. Part II: The pharmacology of brain protection.

Authors:  R Hall; J Murdoch
Journal:  Can J Anaesth       Date:  1990-10       Impact factor: 5.063

3.  Dynamics of interstitial and intracellular pH in evolving brain infarct.

Authors:  M Nedergaard; R P Kraig; J Tanabe; W A Pulsinelli
Journal:  Am J Physiol       Date:  1991-03

4.  Neuroprotective properties of a protein kinase inhibitor against ischaemia-induced neuronal damage in rats and gerbils.

Authors:  S Satoh; I Ikegaki; Y Suzuki; T Asano; M Shibuya; H Hidaka
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

5.  Neuronal lesions and behavioral modifications in rat following cerebral ischemia and reperfusion.

Authors:  G Martinez; M L Carnazza; C D Giacomo; V Sorrenti; R Castana; G Pennisi; J R Perez-Polo; A Vanella
Journal:  Neurochem Res       Date:  1996-06       Impact factor: 3.996

6.  Inhibition of lipid peroxidation by some dihydropyridine derivatives.

Authors:  A Sakamoto; S T Ohnishi; R Ogawa
Journal:  J Anesth       Date:  1993-04       Impact factor: 2.078

7.  Therapeutic effects of nilvadipine on rat focal cerebral ischemia.

Authors:  Y Li; S Kawamura; N Yasui; M Shirasawa; H Fukasawa
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

8.  Nimodipine does not affect the flow-metabolism couple in permanent cerebral ischemia.

Authors:  Shintaro Gomi; Mark G Burnett; Andrea Karp; Joel H Greenberg
Journal:  Exp Brain Res       Date:  2004-01-30       Impact factor: 1.972

9.  Influence of nimodipine on cerebral blood flow in human cerebral ischaemia.

Authors:  C Pozzilli; V Di Piero; P Pantano; M Rasura; G L Lenzi
Journal:  J Neurol       Date:  1989-05       Impact factor: 4.849

10.  'Therapeutic window's for multiple drug treatment of experimental cerebral ischemia in gerbils.

Authors:  D B Stanimirovic; D V Micic; M Markovic; M Spatz; B B Mrsulja
Journal:  Neurochem Res       Date:  1994-02       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.